cysteine has been researched along with Encephalopathy, Toxic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (73.33) | 29.6817 |
| 2010's | 2 (13.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ajao, MS; Akingbade, GT; Aschner, M; Ijomone, OM; Imam, A | 1 |
| Bhatia, P; Singh, N | 1 |
| Mahmoud, YI; Sayed, SS | 1 |
| Diaz-Muñoz, M; Garcia, E; Giordano, M; Herrera-Mundo, MN; Limon, D; Maldonado, PD; Pedraza-Chaverri, J; Perez-De La Cruz, V; Santamaria, A | 1 |
| Akaike, A; Kaneko, S; Katsuki, H; Kume, T; Nishikawa, H; Sugimoto, H; Taguchi, R; Terauchi, T; Yonaga, M | 1 |
| Aguayo, LG; Aranda, M; Hallier, E; Morales, B; Müller, M; Oyarce, M; Pancetti, F; Parodi, J; Westphal, G; Zeise, ML | 1 |
| Barría, MI; Bush, AI; Cerpa, WF; Chacón, MA; González, M; Inestrosa, NC; Opazo, C; Suazo, M | 1 |
| Aguilera, P; Galván-Arzate, S; Maldonado, PD; Medina-Campos, ON; Ortíz-Plata, A; Pedraza-Chaverrí, J; Pérez-Severiano, F; Rodríguez-Pérez, M; Sánchez-García, A; Santamaría, A; Villeda-Hernández, J | 1 |
| Olney, JW | 1 |
| Lee, HG; Lin, D; Liu, Q; Perry, G; Sayre, LM; Smith, MA | 1 |
| LoPachin, RM | 1 |
| Barber, DS; LoPachin, RM | 1 |
| Das, S; Gavin, T; Geohagen, BC; LoPachin, RM | 1 |
| Barber, DS; LoPachin, RM; Stevens, S | 1 |
| Ferrer, JV; Javitch, JA; Kuhn, DM; Park, SU | 1 |
4 review(s) available for cysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Homocysteine excess: delineating the possible mechanism of neurotoxicity and depression.
Topics: Cysteine; Depression; Homocysteine; Humans; Hyperhomocysteinemia; Neurotoxicity Syndromes; S-Adenosylmethionine | 2015 |
Excitatory neurotoxins as food additives: an evaluation of risk.
Topics: Adult; Age Factors; Aspartame; Aspartic Acid; Blood-Brain Barrier; Child; Cysteine; Dietary Supplements; Electrophysiology; Excitatory Amino Acids; Female; Food Analysis; Glutamic Acid; Humans; Neurotoxicity Syndromes; Neurotoxins; Pregnancy; Protein Hydrolysates; Risk Assessment; Risk Factors; Species Specificity | 1981 |
Acrylamide neurotoxicity: neurological, morhological and molecular endpoints in animal models.
Topics: Acrylamide; Acrylamides; Animals; Cell Membrane; Chemical Industry; Cysteine; Disease Models, Animal; Electrophysiology; Humans; Muscle, Skeletal; Nerve Degeneration; Nervous System Diseases; Neurons; Neurotoxicity Syndromes; Neurotoxins; Rats; Temperature; Time Factors | 2005 |
Synaptic cysteine sulfhydryl groups as targets of electrophilic neurotoxicants.
Topics: Animals; Binding Sites; Cysteine; Neurotoxicity Syndromes; Neurotransmitter Agents; Nitric Oxide; Rats; Signal Transduction; Sulfhydryl Compounds; Synapses; Xenobiotics | 2006 |
11 other study(ies) available for cysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
D-Ribose-L-Cysteine Improves Glutathione Levels, Neuronal and Mitochondrial Ultrastructural Damage, Caspase-3 and GFAP Expressions Following Manganese-Induced Neurotoxicity.
Topics: Animals; Caspase 3; Cysteine; Glial Fibrillary Acidic Protein; Glutathione; Male; Manganese; Microscopy, Electron, Scanning; Mitochondria; Neurotoxicity Syndromes; Rats; Rats, Wistar; Thiazolidines | 2021 |
Effects of L-cysteine on lead acetate induced neurotoxicity in albino mice.
Topics: Animals; Brain; Cysteine; Male; Mice; Neurons; Neurotoxicity Syndromes; Organometallic Compounds | 2016 |
Lipid peroxidation, mitochondrial dysfunction and neurochemical and behavioural deficits in different neurotoxic models: protective role of S-allylcysteine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antioxidants; Basal Ganglia; Behavior, Animal; Biomarkers; Cysteine; Disease Models, Animal; Dopamine; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria; Motor Activity; MPTP Poisoning; Neuroprotective Agents; Neurotoxicity Syndromes; Nitro Compounds; Oxidative Stress; Oxidopamine; Propionates; Rats; Rats, Wistar; Synaptosomes; Time Factors | 2008 |
Serofendic acid prevents acute glutamate neurotoxicity in cultured cortical neurons.
Topics: Animals; Calcium; Cattle; Cell Survival; Cells, Cultured; Cerebral Cortex; Cysteine; Diterpenes; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Combinations; Fetal Blood; Fetus; Ionomycin; Neurons; Neurotoxicity Syndromes; Nitric Oxide; Quinoxalines; Rats; S-Nitrosothiols; Sodium Glutamate; Time Factors; Valine | 2003 |
S-methylcysteine may be a causal factor in monohalomethane neurotoxicity.
Topics: Animals; Cells, Cultured; Cysteine; Electric Stimulation; Electrophysiology; gamma-Aminobutyric Acid; Hippocampus; Hydrocarbons, Halogenated; Male; Microscopy, Fluorescence; Neuronal Plasticity; Neurotoxicity Syndromes; Organ Culture Techniques; Patch-Clamp Techniques; Propidium; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Synapses; Synaptic Transmission | 2004 |
The N-terminal copper-binding domain of the amyloid precursor protein protects against Cu2+ neurotoxicity in vivo.
Topics: Amyloid beta-Protein Precursor; Animals; Binding Sites; Caenorhabditis elegans Proteins; Copper; Cysteine; Gliosis; Humans; Ion Transport; Membrane Proteins; Memory; Neurons; Neurotoxicity Syndromes; Peptides; Protein Structure, Tertiary; Proteins; Rats; Tyrosine | 2004 |
S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
Topics: Animals; Antioxidants; Behavior, Animal; Blotting, Western; Body Weight; Cysteine; Garlic; Glutathione Peroxidase; Lipid Peroxidation; Male; Neostriatum; Neurotoxicity Syndromes; Oxidative Stress; Quinolinic Acid; Rats; Rats, Wistar; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Superoxide Dismutase | 2004 |
4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal.
Topics: Aldehydes; Butylamines; Cell Line; Cell Survival; Cysteine; Cysteine Proteinase Inhibitors; Histidine; Humans; Immunohistochemistry; Indicators and Reagents; Kinetics; Lysine; Neurons; Neurotoxicity Syndromes; Oxidative Stress; Proteins; Schiff Bases; Spectrophotometry, Ultraviolet | 2005 |
Neurotoxic mechanisms of electrophilic type-2 alkenes: soft soft interactions described by quantum mechanical parameters.
Topics: 1-Propanol; Acrolein; Acrylamide; Acrylates; Alkenes; Animals; Butanones; Corpus Striatum; Cysteine; Dopamine; Ethylmaleimide; Male; Neurotoxicity Syndromes; Propanols; Quantum Theory; Rats; Rats, Sprague-Dawley; Synaptosomes | 2007 |
Proteomic analysis of rat striatal synaptosomes during acrylamide intoxication at a low dose rate.
Topics: Acrylamide; Animals; Basal Ganglia; Body Weight; Chromatography, Liquid; Cysteine; Gait; Isotope Labeling; Male; Nerve Tissue Proteins; Neurotoxicity Syndromes; Proteomics; Rats; Rats, Sprague-Dawley; Synaptosomes; Tandem Mass Spectrometry; Time Factors | 2007 |
Peroxynitrite inactivates the human dopamine transporter by modification of cysteine 342: potential mechanism of neurotoxicity in dopamine neurons.
Topics: Antioxidants; Biological Transport; Biotin; Cell Line; Cysteine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Free Radical Scavengers; Humans; Kidney; Membrane Glycoproteins; Membrane Transport Modulators; Membrane Transport Proteins; Mutagenesis, Site-Directed; Nerve Tissue Proteins; Neurons; Neurotoxicity Syndromes; Peroxynitrous Acid; Structure-Activity Relationship; Substrate Specificity; Sulfhydryl Reagents; Transfection | 2002 |